Published January 16, 2009 | Version v1
Journal article

SUMOylation of RORα potentiates transcriptional activation function

  • 1. Department of Biological Sciences, Research Center for Women's Disease, Sookmyung Women's University, 52 Hyochangwon-gil, Yongsan-gu, Seoul 140-742 (Korea, Republic of)
  • 2. Department of Biological Sciences, Seoul National University, Seoul 151-742 (Korea, Republic of)
  • 3. Department of Medical Sciences, Inha University, Incheon 402-751 (Korea, Republic of)

Description

SUMOylation regulates a variety of cellular processes, including control of transcriptional activities of nuclear receptors. Here, we present SUMOylation of orphan nuclear receptor, RORα by both SUMO-1 and SUMO-2. SUMOylation of RORα occurred on the 240th lysine residue at the hinge region of human protein. PIAS family members, PIASxα, PIAS3, and PIASy, increased SUMOylation of RORα, whereas SENP2 specifically removed SUMO from RORα. SUMOylation-defective mutant form of RORα exhibited decreased transcriptional activity on RORα-responsive promoters indicating that SUMOylation may positively regulate transcriptional function of RORα.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2008.11.072

Additional details

Identifiers

DOI
10.1016/j.bbrc.2008.11.072;
PII
S0006-291X(08)02271-7;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
378
Journal Issue
3
Journal Page Range
p. 513-517
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
41006429
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
HUMAN POPULATIONS; LEUKEMIA; LYSINE; MUTANTS; PROMOTERS; RECEPTORS; RETINOIC ACID
Descriptors DEC
AMINO ACIDS; CARBOXYLIC ACID ESTERS; CARBOXYLIC ACIDS; DISEASES; ESTERS; IMMUNE SYSTEM DISEASES; MEMBRANE PROTEINS; NEOPLASMS; ORGANIC ACIDS; ORGANIC COMPOUNDS; POPULATIONS; PROTEINS

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.